| NRX PHARMACEUTICALS |
| USA |
| Gesundheit |
| US6294442099 / A4091K |
| B1Q (Frankfurt) / NRXP (NASDAQ) |
| FRA:B1Q, ETR:B1Q, B1Q:GR, NASDAQ:NRXP |
| - |
| https://www.nrxpharma.com.. |
|
NRX Pharmaceuticals Inc. is a biopharmaceutical co..
>Volltext.. |
| 51.16 Mio. EUR |
| 53.94 Mio. EUR |
| 0.21 Mio. EUR |
| -13.11 Mio. EUR |
| -32.84 Mio. EUR |
| -2.03 EUR |
| 8.98 Mio. EUR |
| 6.2 Mio. EUR |
| -10.24 Mio. EUR |
| 0.18 |
| - |
| -86.76% |
| - |
| - |
| - |
| - |
| NRX PHARMACEUTICALS, NRX PHARMA, NRX PHARMACEUTICAL |
| 18.11.25 |
|
||||
|